Polaryx Therapeutics Inc (PLYX) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Polaryx Therapeutics Inc   (NASDAQ: PLYX)

Polaryx Therapeutics Inc

Officers & Directors


Dr. Ronald B. Moss, former Chief Medical Officer, was granted 400,000 restricted stock units (RSUs) on September 1, 2025. Mr. Andrew O received 700,000 RSUs on the same date. As of December 31, 2025, Dr. Moss held no outstanding RSUs, while Mr. O held 608,228 vested RSUs and 1,277,500 unvested RSUs, which are subject to change in control conditions. Other executive officers and directors include G. Michael Landis, CPA; Lisa L. Bollinger, M.D.; Mitchel Berger, M.D.; and Francis A. Braun III, CPA, with noted stock ownership percentages.








PLYX Management Effectiveness PLYX Revenue per Employee PLYX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.